Press release
Glomerulonephritis Market Report Examines Leading Companies And Growth Opportunities
Glomerulonephritis Market
Projected Expansion and Market Size of the Glomerulonephritis Market
The glomerulonephritis market is anticipated to experience steady growth, reaching a value of $14.66 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 4.7%. Several factors are contributing to this rise, including improvements in renal diagnostics, the advancement of precision nephrology, a growing number of chronic kidney disease cases, the broader availability of specialized nephrology care, and better adherence to treatment protocols. Additionally, trends expected to impact this market include a stronger focus on early diagnosis of kidney diseases, increased use of immunosuppressive therapies, wider adoption of biomarker-based testing, the growth of dialysis support services, and enhanced management of chronic conditions.
The glomerulonephritis market size has grown steadily in recent years. It will grow from $11.61 billion in 2025 to $12.18 billion in 2026 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to prevalence of autoimmune disorders, kidney biopsy adoption, growth of nephrology clinics, availability of immunosuppressive drugs, diagnostic laboratory expansion.
Download a free sample of the glomerulonephritis market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21193&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Key Companies Driving the Glomerulonephritis Market Forward
The glomerulonephritis market features several leading pharmaceutical and biotech companies, such as Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Anthera Pharmaceuticals Inc., Chinook Therapeutics, Purespring Therapeutics, Walden Biosciences, and Visterra Inc. One notable partnership occurred in May 2023, when China-based Rona Therapeutics Inc. teamed up with Keymed Biosciences Inc. to develop innovative siRNA therapies for glomerulonephritis. This collaboration aims to introduce first-in-class medicines to meet urgent treatment needs.
Emerging Trends Highlight Opportunities in the Glomerulonephritis Market
A significant shift within the glomerulonephritis market centers on the development of advanced treatments that do not suppress the immune system, addressing unmet needs and enhancing patient outcomes. These non-immunosuppressive therapies aim to treat kidney conditions without compromising immune defenses. For example, in September 2024, US company Travere Therapeutics Inc. launched FILSPARI (sparsentan), the first FDA-approved drug specifically designed to slow kidney function decline in patients with IgA nephropathy, a common form of primary glomerulonephritis. This medication represents a breakthrough by offering an alternative for patients who previously had limited therapeutic options, underscoring Travere's dedication to improving kidney disease treatments.
View the full glomerulonephritis market report:
https://www.thebusinessresearchcompany.com/report/glomerulonephritis-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Breakdown of the Glomerulonephritis Market by Key Segments
The market is segmented across multiple categories for a comprehensive understanding:
1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis
2) By Diagnosis Method: Urine and Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnostic Techniques
3) By Treatment Approach: Medication, Surgery, Dialysis, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Channels
5) By End-User: Hospitals, Specialty Clinics, Other Healthcare Providers
Further subcategories include:
- For Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome
- For Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis
This detailed segmentation helps to better target therapies and diagnostics, reflecting the diverse nature of glomerulonephritis conditions and treatment needs.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glomerulonephritis Market Report Examines Leading Companies And Growth Opportunities here
News-ID: 4607574 • Views: …
More Releases from The Business Research Company
Healthcare Extended Reality Market Outlook Signals Expansion To $45.29 Billion T …
The healthcare extended reality sector is on the verge of remarkable growth, driven by technological advancements and increasing demand for innovative medical solutions. As immersive technologies become more integrated into healthcare, the market is set to expand rapidly, offering new opportunities for patient care, training, and treatment.
Healthcare Extended Reality Market Size and Forecast Through 2030
The healthcare extended reality market is projected to experience significant expansion, reaching a valuation…
Hair Loss Telehealth Market Research Explores Growth Within A $7.44 Billion Oppo …
The hair loss telehealth market is rapidly evolving, driven by technological advancements and shifting patient preferences toward remote healthcare solutions. This sector is poised for remarkable expansion as personalized services and digital platforms redefine how hair loss treatments are accessed and managed globally. Below is an in-depth overview of the market's size, key players, emerging trends, and segment classifications.
Projected Expansion and Market Value of the Hair Loss Telehealth Sector …
Healthcare Environmental Services Market Report 2026 Market Outlook Supported By …
The healthcare environmental services sector is poised for significant expansion as hospitals and medical facilities increasingly prioritize cleanliness, safety, and infection control. With technological advancements and a greater focus on sustainable and automated solutions, this market is set to undergo transformative growth in the coming years. Let's explore the current market size, driving factors, key players, prevailing trends, and segment-wise outlook of this important industry.
Healthcare Environmental Services Market Size and…
Gyneco-Obstetric Ultrasound Systems Market Analysis Highlights Growth To $4.2 Bi …
The gyneco-obstetric ultrasound systems market is on track for significant expansion as healthcare technologies continue to advance and demands for specialized diagnostic tools increase. This sector is gaining momentum due to several factors, including technological progress and a greater emphasis on maternal health monitoring, setting the stage for notable developments by 2030.
Projected Market Value and Growth Trajectory of the Gyneco-Obstetric Ultrasound Systems Market
The market for gyneco-obstetric ultrasound systems…
More Releases for Glomerulonephritis
Emerging Growth Patterns Driving Rapid Expansion in the Glomerulonephritis Marke …
The glomerulonephritis market is positioned for consistent expansion as we approach 2030, driven by technological advances and growing healthcare needs. This sector is witnessing significant progress in diagnostic and therapeutic approaches, which are expected to support the market's upward trajectory. Below is a detailed overview of the market size, key players, segmentation, and current trends shaping this field.
Projected Market Size and Growth in the Glomerulonephritis Market
The glomerulonephritis market…
Immune Complex Membranoproliferative Glomerulonephritis Market Forecast 2034
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) is a rare, chronic kidney disorder characterized by immune complex deposition in the glomeruli, leading to persistent inflammation, progressive renal damage, and potential progression to end-stage renal disease. Management relies on immunosuppressive therapy, biologics, supportive care, dialysis, and kidney transplantation in advanced cases.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/70784
Market Size & Growth
• 2024 Market Value: ~USD 1.2 billion
• 2034 Market Forecast: ~USD 3.8 billion
• CAGR (2025-2034):…
Global Glomerulonephritis Market: Major Trends Reshaping the Future of the Indus …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Glomerulonephritis Industry Market Size Be by 2025?
The market for glomerulonephritis has experienced consistent expansion recently, projected to increase its valuation from $11.06 billion in 2024 to $11.61 billion the following year, reflecting a 4.9% compound annual growth rate. This historical upward trend is largely driven…
Glomerulonephritis Industry Report 2025-2034: Market Dynamics, Trends, And Forec …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Expected Glomerulonephritis Market Size During the Forecast Period?
In recent years, the market size of glomerulonephritis has shown appreciable growth. It is predicted to escalate from $11.06 billion in 2024 to $11.64 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth…
Glomerulonephritis Market: An In-Depth Analysis
Glomerulonephritis is a condition affecting the kidneys, specifically the glomeruli, which are small blood vessels responsible for filtering waste from the blood. When these glomeruli become inflamed, it can lead to impaired kidney function. Glomerulonephritis can be caused by infections, autoimmune diseases, or other underlying health conditions. Its significance lies in its potential to cause chronic kidney disease (CKD) or end-stage renal failure if left untreated. With an increasing prevalence…
Glomerulonephritis Market to Grasp Outstanding CAGR of 4.70% by 2029
The glomerulonephritis market is expected to witness market growth at a rate of 4.70% in the forecast period of 2022 to 2029. Data Bridge Market Research report on glomerulonephritis market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in healthcare sector globally is escalating the growth of glomerulonephritis market.
Get Full Report: https://www.databridgemarketresearch.com/reports/global-glomerulonephritis-market
Glomerulonephritis…
